This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Sell These 4 Toxic Stocks to Prevent Portfolio Losses
by Lavina Shahu
The basic understanding of toxic stocks can help investors avoid huge losses and derive maximum benefit from their portfolios. Some toxic stocks that investors may consider dumping are BROS, CHGG, PI and ANGO.
Compared to Estimates, Dutch Bros (BROS) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Dutch Bros (BROS) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Dutch Bros (BROS) Reports Break-Even Earnings for Q1
by Zacks Equity Research
Dutch Bros (BROS) delivered earnings and revenue surprises of 100% and 5.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Monster Beverage (MNST) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Monster Beverage (MNST) delivered earnings and revenue surprises of 11.76% and 0.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Dutch Bros (BROS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Dutch Bros (BROS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CCEP or BROS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. BROS: Which Stock Is the Better Value Option?
Zacks.com featured highlights Dutch Bros, UBS, CoStar, and Semtech
by Zacks Equity Research
Dutch Bros, UBS, CoStar, and Semtech have been highlighted in this Screen of The Week article.
Discard These 4 Toxic Stocks to Safeguard Your Portfolio
by Lavina Shahu
The correct detection and removal of toxic stocks at the correct time are crucial to overall portfolio health. You should sell BROS, UBS, CSGP and SMTC.
Vita Coco Company, Inc. (COCO) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Vita Coco Company, Inc. (COCO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Dutch Bros (BROS) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Dutch Bros (BROS) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Dutch Bros (BROS) Q4 Earnings Miss Estimates
by Zacks Equity Research
Dutch Bros (BROS) delivered earnings and revenue surprises of -57.14% and 2.07%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Monster Beverage (MNST) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Monster Beverage (MNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dutch Bros (BROS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Dutch Bros (BROS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMX or BROS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FMX vs. BROS: Which Stock Is the Better Value Option?
Zacks Investment Ideas feature highlights: Lyft, Dutch Bros, Airbnb, Meta Platforms and Tesla
by Zacks Equity Research
Lyft, Dutch Bros, Airbnb, Meta Platforms and Tesla have been highlighted in this Investment Ideas article.
Can the IPO Market Produce New Leaders? 3 Attributes to Look For
by Andrew Rocco
The IPO market has been challenging due to a tough macro environment. Andrew Rocco breaks down 3 attributes that IPOs will show if they are to turn around.
How Much Upside is Left in Dutch Bros (BROS)? Wall Street Analysts Think 28.25%
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in Dutch Bros (BROS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
New Strong Buy Stocks for January 19th
by Zacks Equity Research
TME, MANU, BROS, VZLA and EVBG have been added to the Zacks Rank #1 (Strong Buy) List on January 19, 2022.
New Strong Buy Stocks for January 17th
by Zacks Equity Research
PNNT, MITSY, TME, RYAM and BROS have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2022.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Dutch Bros (BROS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Dutch Bros (BROS) delivered earnings and revenue surprises of 50% and 1.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
FEMSA (FMX) to Expand Digital Payments With NetPay Buyout
by Zacks Equity Research
FEMSA (FMX) entered a deal to acquire NetPay to expand its digital payment portfolio, and support micro, small and medium-sized businesses in Mexico.
Dutch Bros Q3 Preview: Can Shares Find New Life?
by Derek Lewis
BROS shares have experienced wide price swings in 2022, down more than 35% overall.
Is a Surprise Coming for Dutch Bros (BROS) This Earnings Season?
by Zacks Equity Research
Dutch Bros (BROS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
22nd Century Group (XXII) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
22nd Century (XXII) delivered earnings and revenue surprises of -20% and 1.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?